Silvia Bio
PrivateLast Round
Seed
Oct 15, 2026
Total Funding Raised
$3.99M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Silvia Bio operates in Healthcare & Life Sciences and is based in Sheffield. Its latest recorded funding round was a Seed round in October 2026.
Silvia Bio is a biotechnology company that provides a platform to accelerate biomanufacturing by identifying cellular bottlenecks and delivering precision media solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Silvia Bio Comparables
Compare Silvia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 64x Bio | 76% | |
| Nucleus Biologics | 76% | |
| InVitria | 75% |
For institutional investors. Book with your work email.
Silvia Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Silvia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UK Innovation & Science Seed Fund | Seed |
| Northern Gritstone | Seed |
| Parkwalk Advisors | Seed |
| Wren Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2026
$4M round led by Northern Gritstone.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesOct 16, 2026
Silvia Bio Ltd plans to move from university facilities to dedicated laboratory premises at Sheffield’s Innovation Centre, with funding enabling the expansion.
- receives_financingOct 15, 2026
Silvia Bio Ltd secures $3.97M in Seed financing led by Northern Gritstone, with participation from Parkwalk, the UK Innovation & Science Seed Fund, Wren Capital, and angel investors, to reduce the cost of producing biologic drugs on Oct 15th '26 in the United Kingdom.
- is_developingOct 15, 2026
Silvia Bio Ltd develops small-molecule additives for use in bioreactors to correct manufacturing issues and intends to license them.
For institutional investors. Book with your work email.
Silvia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Silvia Bio's valuation, stock price, and market status.
Is Silvia Bio a public or private company?
Silvia Bio is a private company.
What is the current stock price of Silvia Bio?
Silvia Bio is a private company, so its shares have no public market price. Caplight tracks Silvia Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Silvia Bio worth (valuation)?
Valuation information for Silvia Bio is not publicly available.
Can I buy Silvia Bio stock?
Silvia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Silvia Bio's last funding round?
Silvia Bio's most recent funding round was Seed on October 15, 2026.
Who are the main investors in Silvia Bio?
Key investors in Silvia Bio include Northern Gritstone.
Will Silvia Bio IPO soon?
No public IPO plans have been announced for Silvia Bio.
How can I track Silvia Bio secondary market activity?
Caplight tracks bids, offers, and trades in Silvia Bio's shares on secondary markets.